US FDA orders boxed warning for all glitazones

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2007年 / 1165卷 / 1期

关键词：

Heart Failure; Rosiglitazone; Pioglitazone; Thiazolidinedione; Actos;

D O I：

10.2165/00128415-200711650-00006

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[1] US FDA requires boxed warning and REMS for metoclopramide
Reactions Weekly, 2009, 1242 (1) : 2 - 2
[2] US FDA removes boxed warning from canagliflozin products
Reactions Weekly, 2020, 1820 (1) : 5 - 5
[3] US FDA votes for ban or boxed warning on paracetamol combination products
Reactions Weekly, 2009, 1260 (1) : 2 - 2
[4] The US FDA has added a new boxed warning to Plavix [clopidogrel].
Reactions Weekly, 2010, 1293 (1) : 2 - 2
[5] FDA approves Multaq with a boxed warning
Reactions Weekly, 2009, 1260 (1) : 3 - 3
[6] FDA Assigns Boxed Warning To Montelukast
Passi, Gouri Rao
INDIAN PEDIATRICS, 2020, 57 (04) : 381 - 381
[7] FDA in favour of boxed warning for Xolair
Reactions Weekly, 2007, 1141 (1) : 4 - 4
[8] FDA Calls for Boxed Warning for Metoclopramide
Lang, Les
GASTROENTEROLOGY, 2009, 136 (07) : 2039 - 2039
[9] A Boxed Warning for Montelukast: The FDA Perspective
Clarridge, Katherine
Chin, Stacy
Eworuke, Efe
Seymour, Sally
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (07): : 2638 - 2641
[10] Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning
Bratsman, Andrew
Mathias, Kristen
Laubscher, Rory
Grigoryan, Larissa
Rose, Stacey
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (06) : 701 - 707

← 1 2 3 4 5 →